File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.ejphar.2004.07.023
- Scopus: eid_2-s2.0-4744342354
- PMID: 15464031
- WOS: WOS:000224635400017
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Pharmacological effects of green tea on the gastrointestinal system
Title | Pharmacological effects of green tea on the gastrointestinal system |
---|---|
Authors | |
Keywords | (-)-Epigallocatechin gallate Catechin Gastrointestinal tract Green tea Tea polyphenol |
Issue Date | 2004 |
Publisher | Elsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/ejphar |
Citation | European Journal Of Pharmacology, 2004, v. 500 n. 1-3 SPEC. ISS., p. 177-185 How to Cite? |
Abstract | Green tea is rich in polyphenolic compounds, with catechins as its major component. Studies have shown that catechins possess diverse pharmacological properties that include anti-oxidative, anti-inflammatory, anti-carcinogenic, anti-arteriosclerotic and anti-bacterial effects. In the gastrointestinal tract, green tea was found to activate intracellular antioxidants, inhibit procarcinogen formation, suppress angiogenesis and cancer cell proliferation. Studies on the preventive effect of green tea in esophageal cancer have produced inconsistent results; however, inverse relationships of tea consumption with cancers of the stomach and colon have been widely reported. Green tea is effective to prevent dental caries and reduce cholesterols and lipids absorption in the gastrointestinal tract, thus benefits subjects with cardiovascular disorders. As tea catechins are well absorbed in the gastrointestinal tract and they interact synergistically in their disease-modifying actions, thus drinking unfractionated green tea is the most simple and beneficial way to prevent gastrointestinal disorders. © 2004 Elsevier B.V. All rights reserved. |
Persistent Identifier | http://hdl.handle.net/10722/171369 |
ISSN | 2023 Impact Factor: 4.2 2023 SCImago Journal Rankings: 1.055 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Koo, MWL | en_US |
dc.contributor.author | Cho, CH | en_US |
dc.date.accessioned | 2012-10-30T06:13:39Z | - |
dc.date.available | 2012-10-30T06:13:39Z | - |
dc.date.issued | 2004 | en_US |
dc.identifier.citation | European Journal Of Pharmacology, 2004, v. 500 n. 1-3 SPEC. ISS., p. 177-185 | en_US |
dc.identifier.issn | 0014-2999 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/171369 | - |
dc.description.abstract | Green tea is rich in polyphenolic compounds, with catechins as its major component. Studies have shown that catechins possess diverse pharmacological properties that include anti-oxidative, anti-inflammatory, anti-carcinogenic, anti-arteriosclerotic and anti-bacterial effects. In the gastrointestinal tract, green tea was found to activate intracellular antioxidants, inhibit procarcinogen formation, suppress angiogenesis and cancer cell proliferation. Studies on the preventive effect of green tea in esophageal cancer have produced inconsistent results; however, inverse relationships of tea consumption with cancers of the stomach and colon have been widely reported. Green tea is effective to prevent dental caries and reduce cholesterols and lipids absorption in the gastrointestinal tract, thus benefits subjects with cardiovascular disorders. As tea catechins are well absorbed in the gastrointestinal tract and they interact synergistically in their disease-modifying actions, thus drinking unfractionated green tea is the most simple and beneficial way to prevent gastrointestinal disorders. © 2004 Elsevier B.V. All rights reserved. | en_US |
dc.language | eng | en_US |
dc.publisher | Elsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/ejphar | en_US |
dc.relation.ispartof | European Journal of Pharmacology | en_US |
dc.subject | (-)-Epigallocatechin gallate | - |
dc.subject | Catechin | - |
dc.subject | Gastrointestinal tract | - |
dc.subject | Green tea | - |
dc.subject | Tea polyphenol | - |
dc.subject.mesh | Anticarcinogenic Agents - Pharmacology | en_US |
dc.subject.mesh | Biological Availability | en_US |
dc.subject.mesh | Camellia Sinensis - Chemistry | en_US |
dc.subject.mesh | Catechin - Chemistry - Pharmacology | en_US |
dc.subject.mesh | Clinical Trials As Topic | en_US |
dc.subject.mesh | Gastrointestinal Diseases - Prevention & Control | en_US |
dc.subject.mesh | Gastrointestinal Tract - Drug Effects | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Neoplasms - Prevention & Control | en_US |
dc.subject.mesh | Phytotherapy | en_US |
dc.subject.mesh | Plant Extracts - Chemistry - Pharmacokinetics - Pharmacology | en_US |
dc.subject.mesh | Plant Leaves - Chemistry | en_US |
dc.subject.mesh | Tea - Chemistry | en_US |
dc.title | Pharmacological effects of green tea on the gastrointestinal system | en_US |
dc.type | Article | en_US |
dc.identifier.email | Koo, MWL:wlkoo@hku.hk | en_US |
dc.identifier.authority | Koo, MWL=rp00233 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1016/j.ejphar.2004.07.023 | en_US |
dc.identifier.pmid | 15464031 | - |
dc.identifier.scopus | eid_2-s2.0-4744342354 | en_US |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-4744342354&selection=ref&src=s&origin=recordpage | en_US |
dc.identifier.volume | 500 | en_US |
dc.identifier.issue | 1-3 SPEC. ISS. | en_US |
dc.identifier.spage | 177 | en_US |
dc.identifier.epage | 185 | en_US |
dc.identifier.isi | WOS:000224635400017 | - |
dc.publisher.place | Netherlands | en_US |
dc.identifier.scopusauthorid | Koo, MWL=7004550899 | en_US |
dc.identifier.scopusauthorid | Cho, CH=7403100461 | en_US |
dc.identifier.issnl | 0014-2999 | - |